Xuelian Pang
- Topics
- Lymphoma Diagnosis and Treatment (6 papers)Esophageal Cancer Research and Treatment (4 papers)Lung Cancer Treatments and Mutations (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Xuelian Pang
17 papers receiving 160 citations
Peers
Comparison fields: 5 of 40
- Molecular Biology 86
- Pathology and Forensic Medicine 65
- Oncology 54
- Surgery 35
- Immunology 28
Countries citing papers authored by Xuelian Pang
This map shows the geographic impact of Xuelian Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuelian Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuelian Pang more than expected).
Fields of papers citing papers by Xuelian Pang
This network shows the impact of papers produced by Xuelian Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuelian Pang. The network helps show where Xuelian Pang may publish in the future.
Co-authorship network of co-authors of Xuelian Pang
This figure shows the co-authorship network connecting the top 25 collaborators of Xuelian Pang. A scholar is included among the top collaborators of Xuelian Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuelian Pang. Xuelian Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 10 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 14 | |
| 8 | 0 | |
| 9 | 3 | |
| 10 | 15 | |
| 11 | 5 | |
| 12 | 8 | |
| 13 | [Expression levels of miR-181c-3p and miR-5692b in esophageal cancer and their clinical significance]. | 4 |
| 14 | A case of blastic plasmacytoid dendritic cell neoplasm with ecchymotic lesions on the whole body. | 9 |
| 15 | 1 | |
| 16 | Significance of elevated ERK expression and its positive correlation with EGFR in Kazakh patients with esophageal squamous cell carcinoma. | 14 |
| 17 | 37 | |
| 18 | 26 | |
| 19 | [Relationship between rs2274223 and rs3765524 polymorphisms of PLCE1 and risk of esophageal squamous cell carcinoma in a Kazakh Chinese population]. | 6 |
About Xuelian Pang
Xuelian Pang is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology, having authored 19 papers that have together received 162 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (6 papers), Esophageal Cancer Research and Treatment (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (65 citations), Oncology (54 citations) and Cancer Research (25 citations). Xuelian Pang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Chunxia Liu, Wenli Cui, Yunzhao Chen, Xiaobin Cui, Jianming Hu, Weihua Liang, Lan Yang, Xinxia Li, Junna Li and Feng Li. Their work appears in journals such as Biochemical and Biophysical Research Communications, Gene and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.